Yet, expression of hnRNP K seems to be more frequently downregulated (judging by the number of reports) in hemato-oncological diseases, which suggests that this protein can act both as an oncogene and as a tumor suppressor [114]. This evidence concerns the gene HNRNPK and neoplasm.